A novel quantification-driven proteomic strategy identifies an endogenous peptide of pleiotrophin as a new biomarker of Alzheimer’s disease

We present a new, quantification-driven proteomic approach to identifying biomarkers. In contrast to the identification-driven approach, limited in scope to peptides that are identified by database searching in the first step, all MS data are considered to select biomarker candidates. The endopeptid...

Descripción completa

Detalles Bibliográficos
Autores principales: Skillbäck, Tobias, Mattsson, Niklas, Hansson, Karl, Mirgorodskaya, Ekaterina, Dahlén, Rahil, van der Flier, Wiesje, Scheltens, Philip, Duits, Floor, Hansson, Oskar, Teunissen, Charlotte, Blennow, Kaj, Zetterberg, Henrik, Gobom, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5645330/
https://www.ncbi.nlm.nih.gov/pubmed/29042634
http://dx.doi.org/10.1038/s41598-017-13831-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5645330/
https://www.ncbi.nlm.nih.gov/pubmed/29042634
http://dx.doi.org/10.1038/s41598-017-13831-0

Ejemplares similares